These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
965 related articles for article (PubMed ID: 23562534)
1. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension. Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411 [TBL] [Abstract][Full Text] [Related]
3. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397 [TBL] [Abstract][Full Text] [Related]
4. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions. Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850 [TBL] [Abstract][Full Text] [Related]
5. Hot-melt extrusion for enhanced delivery of drug particles. Miller DA; McConville JT; Yang W; Williams RO; McGinity JW J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869 [TBL] [Abstract][Full Text] [Related]
6. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. DiNunzio JC; Miller DA; Yang W; McGinity JW; Williams RO Mol Pharm; 2008; 5(6):968-80. PubMed ID: 19434851 [TBL] [Abstract][Full Text] [Related]
7. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766 [TBL] [Abstract][Full Text] [Related]
8. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388 [TBL] [Abstract][Full Text] [Related]
9. Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane. Tsinman K; Tsinman O; Lingamaneni R; Zhu S; Riebesehl B; Grandeury A; Juhnke M; Van Eerdenbrugh B Pharm Res; 2018 Jun; 35(8):161. PubMed ID: 29926245 [TBL] [Abstract][Full Text] [Related]
11. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate. Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333 [TBL] [Abstract][Full Text] [Related]
12. Development of stabilized itraconazole nanodispersions by using high-gravity technique. Zhang ZL; Le Y; Wang JX; Zhao H; Chen JF Drug Dev Ind Pharm; 2012 Dec; 38(12):1512-20. PubMed ID: 22435399 [TBL] [Abstract][Full Text] [Related]
13. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Mou D; Chen H; Wan J; Xu H; Yang X Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090 [TBL] [Abstract][Full Text] [Related]
14. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation? Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T; Sandhu HK; Talele TT; Serajuddin AT Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566 [TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability. Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445 [TBL] [Abstract][Full Text] [Related]
17. Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability. Fadke J; Desai J; Thakkar H AAPS PharmSciTech; 2015 Dec; 16(6):1434-44. PubMed ID: 25991065 [TBL] [Abstract][Full Text] [Related]
18. Improved oral absorption profile of itraconazole in hypochlorhydria by self-micellizing solid dispersion approach. Kojo Y; Matsunaga S; Suzuki H; Sato H; Seto Y; Onoue S Eur J Pharm Sci; 2017 Jan; 97():55-61. PubMed ID: 27810562 [TBL] [Abstract][Full Text] [Related]
19. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions. Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682 [TBL] [Abstract][Full Text] [Related]
20. Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. Overhoff KA; Moreno A; Miller DA; Johnston KP; Williams RO Int J Pharm; 2007 May; 336(1):122-32. PubMed ID: 17184938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]